Nippon Yusen KK
F:NYKA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nippon Yusen KK
F:NYKA
|
JP |
|
E
|
Ecolab Inc
F:ECJ
|
US |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
A
|
Azenta Inc
F:BA3
|
US |
|
S
|
Skechers USA Inc
F:SKAA
|
US |
|
MTN Group Ltd
OTC:MTNOF
|
ZA |
|
D
|
Dominion Energy Inc
LSE:0IC9
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NYKA's stock price target?
Price Target
24.96
EUR
According to Wall Street analysts, the average 1-year price target for 
NYKA is 24.96 EUR with a low forecast of 13.71 EUR and a high forecast of 36.46 EUR.
What is the Revenue forecast for Nippon Yusen KK?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Nippon Yusen KK?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Nippon Yusen KK?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 11 years is -3%.
What is the Pre-Tax Income forecast for Nippon Yusen KK?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is -2%.
What is the Net Income forecast for Nippon Yusen KK?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 2%.